RAP 0.00% 20.5¢ resapp health limited

Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-154

  1. Dhm
    2,380 Posts.
    lightbulb Created with Sketch. 3493
    Once again I just rang the doctor in charge of conducting the Morayfield health clinic. The clinic is still using the Dx app - he called it beta testing - and he continues to be effusive in his praise for the app. he will continue using Dx for the foreseeable future. As payment in kind, the doctor has written a paper on the clinic's experience with the success of the app and has submitted his paper to a number of health journals. I didn't ask which ones. In addition he has contacted Government departments within the Commonwealth and state governments and reported his findings and the 'excellent utility' of the app. Once again, I didn't press him for amplification of this.

    Suffice to say the doctor finds the application of our device to be both 'highly accurate and very useful'. he also sees Dx as very useful in terms of COPD and ongoing monitoring of COVID patients at home in isolation. Further validation of the success of Dx at the coalface.

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.